Who owns PROTARA THERAPEUTIC INC?

Tip: Access positions for across all investors

Analyze quarterly positions in Protara Therapeutic with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Protara Therapeutic stock

Who bought or sold PROTARA THERAPEUTIC INC this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Opaleye Management 2.7M $5.0M 0% Dec 2023
 View chart
Vanguard Group 428k $802k 0% Dec 2023
 View chart
Boxer Capital 209k $392k 0% Dec 2023
 View chart
Baker Bros. Advisors 200k $374k 0% Dec 2023
 View chart
Ikarian Capital 189k $353k 0% Dec 2023
 View chart
Citadel Advisors 39k $72k 67% Dec 2023
 View chart
Two Sigma Advisers 27k $51k -3% Dec 2023
 View chart
Two Sigma Investments 25k $47k -8% Dec 2023
 View chart
Bank of New York Mellon 18k $34k 0% Dec 2023
 View chart
Assenagon Asset Management 16k $30k 0% Dec 2023
 View chart
Millennium Management 12k $22k -36% Dec 2023
 View chart
ADAR1 Capital Management 2.2k $4.1k 100% Dec 2023
 View chart
UBS Group 916.00 $1.7k 657% Dec 2023
 View chart
Royal Bank of Canada 728.00 $0 46% Dec 2023
 View chart
Wells Fargo & Company 569.00 $1.1k 1% Dec 2023
 View chart
Advisor Group Holdings 100.00 $188.000000 0% Dec 2023
 View chart
Jpmorgan Chase & Co 16.00 $30.000000 45% Dec 2023
 View chart
Bank of America Corporation 6.00 $10.999800 100% Dec 2023
 View chart

Who sold out of Protara Therapeutic?

Fund or Company Name Date Sold Shares Held Valued At
OrbiMed Advisors Sep 2023 773k $1.3M
Dimensional Fund Advisors Sep 2023 14k $23k